• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

WHO’s Kieny: R&D Resolution ‘An Advance That Shows Strong Recommitment’

31/05/2016 by William New, Intellectual Property Watch Leave a Comment

World Health Organization members sent a clear signal at the annual Assembly last week when they committed to step up efforts to find ways to fund research into diseases that results in affordable products, according to the top WHO official working on these issues.

Filed Under: IP Policies, Subscribers, Themes, Venues, English, Health & IP, Innovation/ R&D, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, WHA 2016, WHO

WHA Gets First UN Framework Managing Non-State Actors; Countries Satisfied, Actors Concerned

30/05/2016 by Catherine Saez, Intellectual Property Watch 3 Comments

The first agreement on how to manage relationships between a United Nations organisation and non-governmental actors, such as industry, philanthropic organisations and public interest groups, was adopted on 28 May by the World Health Assembly. The framework, which had been discussed for several years, was hailed as historic by many countries, but met a mixed reaction from those primarily concerned.

Filed Under: IP Policies, Language, Themes, Venues, English, Finance, Health & IP, Lobbying, Patents/Designs/Trade Secrets, United Nations - other, WHA 2016, WHO

Reactions To WHA Resolution On R&D Financing Generally Positive

28/05/2016 by William New, Intellectual Property Watch 1 Comment

Today, the annual World Health Assembly is poised to approve a new plan on research and development into medical products that are affordable to all. NGOs, industry and other observers welcomed the outcome.

Filed Under: IP Policies, Language, Themes, Venues, English, Finance, Health & IP, Innovation/ R&D, Lobbying, Patents/Designs/Trade Secrets, WHA 2016, WHO

Drug Pricing, Generics Figure Into WHO Strategies On HIV, Hepatitis

28/05/2016 by Mara Pillinger for Intellectual Property Watch and William New 1 Comment

As the 69th World Health Assembly draws to a close, member states are being asked to approve a series of draft global health sector strategies for HIV, viral hepatitis, and sexually transmitted infections. And the issues involve some questions of intellectual property rights.

Filed Under: IP Policies, Language, Themes, Venues, English, Health & IP, Patents/Designs/Trade Secrets, WHA 2016, WHO

WHO Drafting Group Agrees Resolution On Health R&D

28/05/2016 by William New, Intellectual Property Watch 1 Comment

A closed-door drafting group this evening arrived seemingly easily at agreement on a resolution on broadening work on new ways to fund research and development into medical products, according to participants. The agreement includes the creation of a new expert committee on health R&D, and asks for a WHO proposal on a pooled fund, they said. [Update: draft text now available]

Filed Under: IP Policies, Language, Themes, Venues, Development, English, Finance, Health & IP, Innovation/ R&D, Patents/Designs/Trade Secrets, WHA 2016, WHO

WHO Reforms Health Emergency Response But Who Will Pay The Bill?

27/05/2016 by Mara Pillinger for Intellectual Property Watch Leave a Comment

Two years after Ebola, the World Health Organization continues to push forward with a thorough overhaul of how it responds to health emergencies. These include Public Health Emergencies of International Concern (PHEICs), such as the Ebola and Zika outbreaks, as well as natural diseases, conflicts, refugee crises, and the like.

Filed Under: IP Policies, Language, Themes, Venues, Development, English, Health & IP, Innovation/ R&D, Patents/Designs/Trade Secrets, Technical Cooperation/ Technology Transfer, WHA 2016, WHO

Drafting Group Finishes Framework On WHO And Outside Actors

27/05/2016 by Catherine Saez, Intellectual Property Watch 1 Comment

If adopted as expected tomorrow by the World Health Assembly, a framework guiding the relationships between the World Health Organization and outside actors will be the first of its kind in the United Nations system, according to sources.

Filed Under: IP Policies, Language, Subscribers, Themes, Venues, English, Finance, Health & IP, Lobbying, Patents/Designs/Trade Secrets, WHA 2016, WHO

Europe Medicines Group Joins Initiative To Fight Fake Medicines

27/05/2016 by Intellectual Property Watch 1 Comment

Medicines for Europe, representing the generic, biosimilar, and medicines in Europe, announced today during a side event at the World Health Assembly, that it joined the Global Campaign to Fight Fake Medicines.

Filed Under: IP-Watch Briefs, IP Policies, Language, Themes, Venues, Enforcement, English, Lobbying, Patents/Designs/Trade Secrets, Trademarks/Geographical Indications/Domains, WHA 2016, WHO

Resolution On WHO Work With Non-State Actors Down To Wire

27/05/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment

With the end of the annual World Health Assembly looming tomorrow, member states are working away behind closed doors to finalise a resolution on how the World Health Organization shall work with outside actors going forward.

Filed Under: IP Policies, Language, Themes, Venues, English, Finance, Health & IP, Lobbying, Patents/Designs/Trade Secrets, WHA 2016, WHO

Against Microbial Resistance Peril, WHA Delegates Discuss Global Solutions, Approve Report

27/05/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment

According to a new report, by 2050, some 10 million lives could be lost a year due to antimicrobial resistance. This is an issue which has been central to this year’s World Health Assembly, and is of global consequence. Delegates gathered for the occasion noted a report by the World Health Organization secretariat on the global action plan on antimicrobial resistance adopted last year and options to develop a global stewardship framework to try to limit the use of antibiotics and develop new ones.

Filed Under: IP Policies, Subscribers, Themes, Venues, English, Health & IP, Innovation/ R&D, Patents/Designs/Trade Secrets, WHA 2016, WHO

  • 1
  • 2
  • 3
  • Next Page »
  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2022 · Global Policy Reporting